Pulmonary Aspergillosis in Solid Organ Transplant Patients: A Report From Iran

Transplantation Proceedings

Volumn 40, Issue 10, 2008, Pages 3663-3667

  Marjani, M ^a   Tabarsi, P ^a   Najafizadeh, K ^a   Farokhi, F R ^a   Sharifkashani, B ^a   Motahari, S ^a   Abbasi, A ^a   Masjedi, M R ^a   Mansouri, D ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; ITRACONAZOLE; THYMOCYTE ANTIBODY; VORICONAZOLE;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLUS TRACHEOBRONCHITIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DEMOGRAPHY; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IRAN; LOADING DRUG DOSE; LUNG ASPERGILLOSIS; LUNG BIOPSY; LUNG TRANSPLANTATION; MALE; MEDICAL RECORD; MONOTHERAPY; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PATIENT INFORMATION; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; RISK FACTOR; TRACHEOBRONCHITIS; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; DEBRIDEMENT; DRUG THERAPY, COMBINATION; FEMALE; HEART TRANSPLANTATION; HUMANS; IRAN; KIDNEY TRANSPLANTATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY ASPERGILLOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS; YOUNG ADULT;

EID: 57649115721     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.06.070     Document Type: Article

References (39)

1. Chandrasekar P.H., Alangaden G., and Manavathu E. Aspergillosis: an increasing problem in tertiary care hospitals. Clin Infect Dis 30 (2000) 984
2. Kartsonis N.A., Saah A.J., Lipka C.J., et al. Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study. J Infect 50 (2005) 196
3. Singh N., Paterson D.L., et al. Aspergillus infections in transplant recipients. Clin Microbiol Rev 18 (2005) 44
4. Nicod L.P., Pache J.C., and Howarth N. Fungal infections in transplant recipients. Eur Respir J 17 (2001) 133
5. Clark T.A., and Hajjeh R.A. Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 15 (2002) 569
6. Alexander B.D. Prophylaxis of invasive mycoses in solid organ transplantation. Curr Opin Infect Dis 15 (2002) 583
7. Denning D.W. Invasive aspergillosis. Clin Infect Dis 26 (1998) 781
8. Patterson J.E., Peters J., Calhoon J.H., et al. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients. Transpl Infect Dis 2 (2000) 22
9. Singh N. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design. Clin Infect Dis 39 (2004) S200
10. Hadjiliadis D., Sporn T.A., Perfect J.R., et al. Outcome of lung transplantation in patients with mycetomas. Chest 121 (2002) 128
11. Mehrad B., Paciocco G., Martinez F.J., et al. Spectrum of Aspergillus infection in lung transplant recipients. Chest 119 (2001) 169
12. Paterson D.L., and Singh N. Invasive aspergillosis in transplant recipients. Medicine 78 (1999) 123
13. Gavalda J., Len O., San Juan R., et al. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis 41 (2005) 52
14. Munoza P., Rodrigueza C., Bouzaa E., et al. Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis. Am J Transplant 4 (2004) 636
15. Raviv Y., Kramer M.R., Amital A., et al. Outbreak of aspergillosis infections among lung transplant recipients. Transpl Int 20 (2007) 135
16. Panackal A.A., Dahlman A., Keik K.T., et al. Outbreak of invasive aspergillosis among renal transplant recipients. Transplantation 75 (2003) 1050
17. Musher B., Fredricks D., Leisenring W., et al. Aspergillus Galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 42 (2004) 5517
18. Hoffer F.A., Gow K., Flynn P.M., et al. Accuracy of percutaneous lung biopsy for invasive pulmonary aspergillosis. Pediatr Radiol 31 (2001) 144
19. Pfeiffer C.D., Fine J.P., and Safdar N. Diagnosis of invasive aspergillosis using a Galactomannan assay: a meta-analysis. Clin Infect Dis 42 (2006) 1417
20. Husain S., Kwak E.J., Obman A., et al. Propsective assessment of Platelia Aspergillus Galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant 4 (2004) 796
21. Ergin F., Arslan H., Azap A., et al. Invasive aspergillosis in solid-organ transplantation: report of eight cases and review of the literature. Transpl Int 16 (2003) 280
22. Horger M., Einsele H., Schumacher U., et al. Invasive pulmonary aspergillosis: frequency and meaning of the "hypodense sign" on unenhanced CT. Br J Radiol 78 (2005) 697
23. Lee P., Minai O.A., Mehta A.C., et al. Pulmonary nodules in lung transplant recipients: etiology and outcome. Chest 125 (2004) 165
24. Montoya J.G., Chaparro S.V., Celis D., et al. Invasive aspergillosis in the setting of cardiac transplantation. Clin Infect Dis 37 suppl 3 (2003) S281
25. Maschmeyer G., and Ruhnke M. Update on antifungal treatment of invasive Candida and Aspergillus infections. Mycoses 47 (2004) 263
26. Patterson D.L., and Singh N. Invasive aspergillosis in transplant recipients. Medicine 78 (1999) 123
27. Lin S., Schranz J., and Teutsch S. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32 (2001) 358
28. Patterson T.F., Kirkpatrick W.R., White M., et al. Invasive aspergillosis disease spectrum, treatment practices, and outcomes. Medicine 79 (2000) 250
29. Segal B.H., and Walsh T.J. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 173 (2006) 707
30. Denning D.W., Ribaud P., Milpied N., et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34 (2002) 563
31. Veroux M., Corona D., Gagliano M., et al. Voriconazole in the treatment of invasive aspergillosis in kidney transplant recipients. Transplant Proc 39 (2007) 1838
32. Herbrecht R., Denning D.W., Patterson T.F., et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347 (2002) 408
33. Walsh T.J., Anaissie E.J., Denning D.W., et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46 (2008) 327
34. Carby M.R., Hodson M.E., and Banner N.R. Refractory pulmonary aspergillosis treated with caspofungin after heart-lung transplantation. Transpl Int 17 (2004) 545
35. Fohrer C., Fornecker L., Nivoix Y., et al. Antifungal combination treatment: a future perspective. Int J Antimicrob Agents 27S (2006) 25
36. Kontoyiannis D.P., Boktour M., Hanna H., et al. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer 103 (2005) 2334
37. Silveira F., and Paterson D.L. Pulmonary fungal infections. Curr Opin Pulm Med 11 (2005) 242
38. Singh N., Limaye A.P., Forrest G., et al. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation 81 (2006) 320
39. Marr K.A., Boeckh M., Carter R.A., et al. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 39 (2004) 797